<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1995">
 <bold>Conclusions:</bold> 1- During CPFA or Cytosorb RRT Heparine increased R (delay in activation of coagulation ) and decreased MA ( less cloth strength ) in patients , increasing the risk of bleeding. 2- 18Â mmol/L citrate anticoagulation decreased MA and increased R in circuits better then in Group A and B, achieving an optimal extracorporeal anticoagulation. (1)
</p>
